A detailed history of Aventura Private Wealth, LLC transactions in Repligen Corp stock. As of the latest transaction made, Aventura Private Wealth, LLC holds 18 shares of RGEN stock, worth $2,742. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18
Holding current value
$2,742
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 07, 2026

BUY
$142.82 - $166.33 $2,570 - $2,993
18 New
18 $2.95 Million
Q3 2025

Jan 07, 2026

BUY
$111.43 - $134.0 $2,451 - $2,948
22 Added 122.22%
40 $5.35 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.46B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Aventura Private Wealth, LLC Portfolio

Follow Aventura Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aventura Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aventura Private Wealth, LLC with notifications on news.